Delivery Order SPE2DB24D2003-SPE2DB25FXKV9
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $17,894.90 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price delivery order is set to be completed by July 21, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at $999,999,999.00...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $37,051.60 to AmerisourceBergen Drug Corp on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA Troop Support Medical. The award is for pharmaceutical and medical supply distribution services, with performance taking place...
- This delivery order, valued at $3,082.67, was awarded on July 18, 2025, to AmerisourceBergen Drug Corp for pharmaceutical supply through the Defense Logistics Agency's Medical Supply Chain program. The award is a competitive, non-set-aside contract with firm fixed pricing, representing a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $65,981.37 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. This firm fixed-price contract, issued on July 18, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order was competitively awarded with no set-aside designation and will...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,564.66 to AmerisourceBergen Drug Corp on July 20, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The delivery order was placed at...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,775.92 by the Defense Logistics Agency's Medical Supply Chain on July 26, 2025, with an ultimate completion date of July 28, 2025. This firm fixed price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,238.48 by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed price, competitively awarded contract (no set-aside designation) represents a child delivery order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp serves as a critical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $16,222.44 to AmerisourceBergen Drug Corp under a firm fixed-price contract with an ultimate completion date of July 28, 2025. This non-set-aside, competitively awarded delivery order represents a discrete task order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $6,164.86 to AmerisourceBergen Drug Corp on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The award was competitively granted with no set-aside designation, and performance will be executed at the contractor's corporate office...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,161.02 to AmerisourceBergen Drug Corp on July 24, 2025. This firm fixed-price, non-set-aside contract is a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) designated SPE2DX with the DLA Troop Support Medical, valued at $999,999,999 and running through December 2026. The work will be performed at the contractor's Corporate Office location in Conshohocken,...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB25FXKV9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,147.29 to AmerisourceBergen Drug Corp for pharmaceutical products and services. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 25, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, supplies a comprehensive range of pharmaceutical products and medical supplies to federal medical procurement needs, particularly for military and veteran healthcare systems. The company's SPE2DX prime contract vehicle serves as a global pharmaceutical support mechanism enabling delivery of specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. This delivery order reflects the company's ongoing role as a critical vendor within DLA's pharmaceutical supply chain and the agency's medical logistics operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 7/24/25 |